Geertrui Denecker

Ghent University — Belgium

Medicine · Health Sciences

39h-index7.6kcitations101works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuroblastoma Research and Treatments(24), Cell death mechanisms and regulation(19), NF-κB Signaling Pathways(7), Skin and Cellular Biology Research(6), Genomics and Chromatin Dynamics(5)

Publications101 total

Data from The EMT Transcription Factor ZEB2 Promotes Proliferation of Primary and Metastatic Melanoma While Suppressing an Invasive, Mesenchymal-Like Phenotype
2023Open Access
Data from The EMT Transcription Factor ZEB2 Promotes Proliferation of Primary and Metastatic Melanoma While Suppressing an Invasive, Mesenchymal-Like Phenotype
2023Open Access
Supplementary Data from The EMT Transcription Factor ZEB2 Promotes Proliferation of Primary and Metastatic Melanoma While Suppressing an Invasive, Mesenchymal-Like Phenotype
2023Open Access
Supplementary Data from The EMT Transcription Factor ZEB2 Promotes Proliferation of Primary and Metastatic Melanoma While Suppressing an Invasive, Mesenchymal-Like Phenotype
2023Open Access
Supplementary Data from The EMT Transcription Factor ZEB2 Promotes Proliferation of Primary and Metastatic Melanoma While Suppressing an Invasive, Mesenchymal-Like Phenotype
2023Open Access
Supplementary Data from The EMT Transcription Factor ZEB2 Promotes Proliferation of Primary and Metastatic Melanoma While Suppressing an Invasive, Mesenchymal-Like Phenotype
2023Open Access
SOX11 regulates SWI/SNF complex components as member of the adrenergic neuroblastoma core regulatory circuitry
Nature Communications·2023· 39 citedOpen Access
Kalirin-RAC controls nucleokinetic migration in ADRN-type neuroblastoma
Life Science Alliance·2021· 4 citedOpen Access
Recurrent chromosomal imbalances provide selective advantage to human embryonic stem cells under enhanced replicative stress conditions
Genes Chromosomes and Cancer·2020· 7 cited
Recurrent chromosomal imbalances provide selective advantage to human embryonic stem cells under enhanced replicative stress conditions
2020Open Access
SOX11 is a lineage-dependency factor and master epigenetic regulator in neuroblastoma
2020· 9 citedOpen Access
The EMT Transcription Factor ZEB2 Promotes Proliferation of Primary and Metastatic Melanoma While Suppressing an Invasive, Mesenchymal-Like Phenotype
Cancer Research·2020· 86 cited
The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness
Scientific Reports·2020· 28 citedOpen Access
Author Correction: Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes
Scientific Reports·2019Open Access
Publisher Correction: In silico discovery of a FOXM1 driven embryonal signaling pathway in therapy resistant neuroblastoma tumors
Scientific Reports·2019Open Access
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes
Scientific Reports·2019· 18 citedOpen Access
17q gain provides proliferative advantage to human embryonic stem cells under replicative stress
Ghent University Academic Bibliography (Ghent University)·2019
17q gain provides proliferative advantage to human embryonic stem cells under conditions of replicative stress
Ghent University Academic Bibliography (Ghent University)·2019
SOX11 as mediator of the adrenergic cell state in NB
Ghent University Academic Bibliography (Ghent University)·2019
SOX11 is a key epigenetic regulator in the adrenergic MYCN amplified neuroblastoma
Ghent University Academic Bibliography (Ghent University)·2019
page 1 of 6Next →

Frequent Co-authors

Peter Vandenabeele(31), Wim Declercq(24), Dominique Vercammen(7), Walter Fiers(7), Saskia Lippens(7), Rudi Beyaert(6), Jean‐Christophe Marine(6), Barbara Gilbert(5), Johan Grooten(4), Esther Hoste(4), Tino Hochepied(4), Petra Ovaere(4), Katharina D’Herde(4), Jean‐Pierre Hachem(4), Kris Gevaert(4), Jody J. Haigh(4), Geert Berx(4), Michaël Kalai(4), Christophe Van Neste(4), Wouter Van Loocke(4)